RxSight (RXST) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free RXST Stock Alerts $62.26 -2.03 (-3.16%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 5:18 PM | marketbeat.comNicholas Investment Partners LP Buys New Position in RxSight, Inc. (NASDAQ:RXST)Nicholas Investment Partners LP acquired a new stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 56,414 shares of the company's stock, valued at approMay 13 at 7:50 PM | finance.yahoo.comRxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesMay 13 at 4:05 PM | globenewswire.comRxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesMay 13 at 4:55 AM | marketbeat.comVictory Capital Management Inc. Has $10.35 Million Holdings in RxSight, Inc. (NASDAQ:RXST)Victory Capital Management Inc. raised its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 108.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 256,684 shares of the company's stock after buying an additional 1May 11, 2024 | americanbankingnews.comRxSight, Inc. (NASDAQ:RXST) Receives Consensus Recommendation of "Buy" from BrokeragesMay 10, 2024 | finance.yahoo.comRxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75May 9, 2024 | msn.comWhy RxSight (RXST) Shares Are FallingMay 9, 2024 | finance.yahoo.comRxSight First Quarter 2024 Earnings: Beats ExpectationsMay 9, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Shares Gap Down to $60.66RxSight (NASDAQ:RXST) Shares Gap Down to $60.66May 9, 2024 | msn.comRxSight price raises equity at $56 per shareMay 9, 2024 | americanbankingnews.comRxSight (NASDAQ:RXST) PT Raised to $72.00May 9, 2024 | americanbankingnews.comNeedham & Company LLC Increases RxSight (NASDAQ:RXST) Price Target to $75.00May 9, 2024 | americanbankingnews.comRxSight (NASDAQ:RXST) PT Raised to $68.00 at Wells Fargo & CompanyMay 8, 2024 | globenewswire.comRxSight, Inc. Announces Pricing of Public Offering of Common StockMay 8, 2024 | markets.businessinsider.comRxSight’s Strong Q1 Performance and Market Expansion Justify Buy RatingMay 8, 2024 | americanbankingnews.comRxSight (NASDAQ:RXST) PT Raised to $68.00May 8, 2024 | americanbankingnews.comRxSight (NASDAQ:RXST) Shares Gap Up Following Analyst UpgradeMay 7, 2024 | markets.businessinsider.comRxSight Outperforms with Strong Q1 Results and Raised Guidance: Buy Rating AffirmedMay 7, 2024 | markets.businessinsider.comWhat 10 Analyst Ratings Have To Say About RxSightMay 7, 2024 | finance.yahoo.comRxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call TranscriptMay 7, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Price Target Raised to $68.00 at Wells Fargo & CompanyWells Fargo & Company increased their price target on RxSight from $61.00 to $68.00 and gave the company an "overweight" rating in a research report on Tuesday.May 7, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Shares Gap Up on Analyst UpgradeRxSight (NASDAQ:RXST) Shares Gap Up on Analyst UpgradeMay 7, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Posts Earnings ResultsRxSight (NASDAQ:RXST - Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by ($0.08). The company had revenue of $29.51 million during the quarter, compared to analyst estimates of $27.56 million. RxSight had a negative net margin of 54.57% and a negative return on equity of 31.16%. The firm's revenue for the quarter was up 68.7% compared to the same quarter last year. During the same quarter last year, the business earned ($0.42) EPS.May 7, 2024 | finance.yahoo.comRxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...May 7, 2024 | americanbankingnews.comRxSight, Inc. (NASDAQ:RXST) CEO Ronald M. Md Kurtz Sells 40,000 Shares of StockMay 7, 2024 | insidertrades.comRxSight, Inc. (NASDAQ:RXST) CEO Sells $2,406,000.00 in StockMay 6, 2024 | marketbeat.comLisanti Capital Growth LLC Reduces Holdings in RxSight, Inc. (NASDAQ:RXST)Lisanti Capital Growth LLC lessened its position in RxSight, Inc. (NASDAQ:RXST - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 110,820 shares of the company's stock after selling 12,385 sMay 6, 2024 | msn.comRXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024May 6, 2024 | finance.yahoo.comRxSight Inc (RXST) Surpasses Analyst Revenue Forecasts in Q1 2024May 6, 2024 | marketbeat.comRonald M. Md Kurtz Sells 40,000 Shares of RxSight, Inc. (NASDAQ:RXST) StockRxSight, Inc. (NASDAQ:RXST - Get Free Report) CEO Ronald M. Md Kurtz sold 40,000 shares of the firm's stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $60.15, for a total value of $2,406,000.00. Following the sale, the chief executive officer now directly owns 764,610 shares of the company's stock, valued at approximately $45,991,291.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.May 6, 2024 | globenewswire.comRxSight, Inc. Reports First Quarter 2024 Financial ResultsMay 6, 2024 | marketbeat.comStifel Nicolaus Raises RxSight (NASDAQ:RXST) Price Target to $68.00Stifel Nicolaus increased their price target on RxSight from $64.00 to $68.00 and gave the company a "buy" rating in a research note on Monday.May 6, 2024 | msn.comStocks Set to Open Higher as Investors Await More Corporate Earnings and Fed SpeakMay 5, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Shares Purchased by New York State Common Retirement FundNew York State Common Retirement Fund grew its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 25.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 135,438 shares of the company's stock after purchasinMay 3, 2024 | insidertrades.comInsider Selling: RxSight, Inc. (NASDAQ:RXST) CFO Sells 10,000 Shares of StockMay 2, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Sets New 52-Week High at $59.16RxSight (NASDAQ:RXST) Hits New 52-Week High at $59.16May 1, 2024 | seekingalpha.comRxSight: Promising Technology, Uncertain Profitability - A Hold RecommendationApril 29, 2024 | marketbeat.comRxSight (RXST) Scheduled to Post Quarterly Earnings on MondayRxSight (NASDAQ:RXST) will be releasing earnings after the market closes on Monday, May 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=587498)April 25, 2024 | finance.yahoo.comShould You Investigate RxSight, Inc. (NASDAQ:RXST) At US$52.84?April 24, 2024 | marketbeat.comFederated Hermes Inc. Sells 47,669 Shares of RxSight, Inc. (NASDAQ:RXST)Federated Hermes Inc. decreased its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 15.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 264,922 shares of the company's stock after sellingApril 22, 2024 | globenewswire.comRxSight, Inc. to Report First Quarter Financial Results on May 6, 2024April 18, 2024 | marketbeat.comReadystate Asset Management LP Buys New Holdings in RxSight, Inc. (NASDAQ:RXST)Readystate Asset Management LP bought a new stake in RxSight, Inc. (NASDAQ:RXST - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 18,060 shares of the company's stock, valued at approximatelyApril 11, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), RxSight (RXST) and Clearside Biomedical (CLSD)April 11, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Stock Rating Reaffirmed by Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $64.00 target price on shares of RxSight in a research note on Thursday.April 11, 2024 | markets.businessinsider.comAssessing RxSight: Insights From 8 Financial AnalystsApril 11, 2024 | marketbeat.comVanguard Group Inc. Has $39.99 Million Position in RxSight, Inc. (NASDAQ:RXST)Vanguard Group Inc. raised its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 21.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,433,953 shares of the company's stock after buying an additional 255,150 shaApril 6, 2024 | investing.comRxSight launches new Light Adjustable Lens productApril 4, 2024 | globenewswire.comRxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual MeetingApril 3, 2024 | insidertrades.comRxSight, Inc. (NASDAQ:RXST) CFO Shelley B. Thunen Sells 20,000 SharesApril 2, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) CFO Sells $998,000.00 in StockRxSight, Inc. (NASDAQ:RXST - Get Free Report) CFO Shelley B. Thunen sold 20,000 shares of the business's stock in a transaction on Monday, April 1st. The stock was sold at an average price of $49.90, for a total transaction of $998,000.00. Following the completion of the sale, the chief financial officer now owns 8,402 shares in the company, valued at approximately $419,259.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. RXST Media Mentions By Week RXST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RXST News Sentiment▼0.820.55▲Average Medical News Sentiment RXST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RXST Articles This Week▼93▲RXST Articles Average Week Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STAAR Surgical News Bausch Health Companies News Warby Parker News National Vision News Edap Tms News ClearPoint Neuro News Neuronetics News Apyx Medical News Bausch + Lomb News Vera Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RXST) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
